Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsResearch in context

Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsResearch in context

Summary: Background: Measles is a highly contagious viral disease. Vaccinated mothers transfer fewer antibodies during pregnancy, resulting in shortened infant immunity. Earlier primary vaccination might avert the gap in protection. Methods: Healthy 5–7-month-old Danish infants were assigned in a 1...

Full description

Bibliographic Details
Main Authors: Dorthe Maria Vittrup, Andreas Jensen, Jesper Kiehn Sørensen, Anne Cathrine Zimakoff, Michelle Malon, Salma Charabi, Marie Ryberg Johansen, Eric A.F. Simões, Nikolai Søren Kirkby, Søren Buus, Jannet Svensson, Lone Graff Stensballe
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:EClinicalMedicine
Subjects:
MMR
Measles vaccination
Early immunization
Immunogenicity
Reactogenicity
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023005989

Similar Items

Similar Items